Shlomo Schneebaum, MD

Surgical Oncologist
Tel Aviv Sourasky Medical Center
Tel Aviv, Tel Aviv, Israel

Presentation(s):

• QS22. Survival and recurrence outcomes for stage IIB/IIC melanoma: risk stratification for immunotherapy and surveillance

  Thursday, March 5, 2026
  3:45 PM - 3:49 PM MST

• BP2. Adjuvant anti-PD-1 therapy in elderly patients with melanoma: an analysis of the Sentinel Lymph Node Working Group cohort

  Friday, March 6, 2026
  8:09 AM - 8:16 AM MST